A Clinical Trial of TQ05105 Tablets in the Treatment of Moderate and High Risk Myelofibrosis

Clinical trial NCT05020652 · COMPLETED

Trial details

NCT number: NCT05020652
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Moderate and High Risk Myelofibrosis

Start date: 2021-11-11
Primary completion: 2023-10-15
Enrollment: 107

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.